Lingnan Modern Clinics in Surgery ›› 2011, Vol. 11 ›› Issue (06): 472-475.
Previous Articles Next Articles
李闻达,陈亚进
通讯作者:
陈亚进
基金资助:CLC Number:
李闻达 陈亚进. 胰腺黏液性囊腺瘤的诊治进展[J]. 岭南现代临床外科, 2011, 11(06): 472-475.
| [1] 安锋铎,邱法波,吴昌亮,等. 中国大陆2000-2010年胰腺囊腺瘤和囊腺癌临床流行病学特征[J]. 中国现代普通外科进展,2011,14(2):140-143.[2] Warshaw AL, Rutledge PL. Cystic tumors mistaken for pan-creatic pseudocysts [J]. Ann Surg, 1987, 205: 393-398.[3] Simeone DM. SSAT/AGA/ASGE state of the art conference on cystic neoplasms of the pancreas[J]. J Gastrointest Surg, 2008, 12: 1475-1477.[4] Reddy RP, Smyrk TC, Zapiach M, et al. Pancreatic muci-nous cystic neoplasm defined by ovarian stroma: demo-graphics, clinical features, and prevalence of cancer[J]. Clin Gastroenterol Hepatol, 2004, 2: 1026-1031.[5] Sarr MG, Carpenter HA, Prabhakar LP, et al. Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or pre-malignant) neoplasms? [J] Ann Surg, 2000, 231: 205-212[6] Zamboni G, Scarpa A, Bogina G, et al. Mucinous cystic tumors of the pancreas: clinico-pathological features, prognosis, and relationship to other mucinous cystic tumors[J]. Am J Surg Pathol, 1999; 23, 410-422.[7] Garcea G, Ong SL, Rajesh A, et al. Cystic lesions of the pancreas. A diagnostic and management dilemma[J]. Pancreatology, 2008, 8: 236-251.[8] 唐雯. 胰腺囊腺瘤和囊腺癌的鉴别诊断[J]. 重庆医学,2009,38 (18): 2361-2371.[9] Fernández-del Castillo C. Mucinous cystic neoplasms[J]. J Gastrointest Surg, 2008, 12: 411-413.[10] Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas[J]. Pancreatology, 2006; 6: 17-32.[11] Garcea G, Ong SL, Rajesh A, et al. Cystic lesions of the pancreas. A diagnostic and management dilemma[J]. Pancreatology, 2008, 8: 236-251.[12] Bassi C, Salvia R, Gumbs AA, et al. The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 125, Ca 15-3[J]. Langenbecks Arch Surg, 2002, 387: 281-285.[13] Sahani DV, Kadavigere R, Saokar A, et al. Cystic pancreatic lesions: a simple imaging-based classification system for guiding management[J]. Radiographics, 2005, 25: 1471-1484.[14] van der Waaij LA, van Dullemen HM, Porte RJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis[J]. Gastrointest Endosc, 2005, 62: 383-389.[15] Van Dam J. EUS in cystic lesions of the pancreas[J]. Gastrointest Endosc, 2002, 56: S91-S93.[16] Shyr YM, Su CH, Tsay SH, et al. Mucin-producing neoplasms of the pancreas. Intraductal papillary and mucinous cystic neoplasms[J]. Ann Surg, 1996; 223: 141-146.[17] Edirimanne S, Connor SJ. Incidental pancreatic cystic lesions[J]. World J Surg, 2008, 32: 2028-2037.[18] Attasaranya S, Pais S, LeBlanc J, et al. Endoscopic ultrasound-guided fine needle aspiration and cyst fluid analysis for pancreatic cysts. JOP 2007, 8: 553-563.[19] Aljebreen AM, Romagnuolo J, Perini R, et al. Utility of endoscopic ultrasound, cytology and fluid carcinoembryonic antigen and CA 19-9 levels in pancreatic cystic lesions[J]. World J Gastroenterol 2007, 13: 3962-3966.[20] Kim SY, Lee JM, Kim SH, et al. Macrocystic neoplasms of the pancreas: CT differentiation of serous oligocystic adenoma from mucinous cystadenoma and intraductal papillary mucinous tumor[J]. AJR Am J Roentgenol, 2006, 187: 1192-1198.[21] Lillemoe KD, Kaushal S, Cameron JL, et al. Distal pancreatectomy: indications and outcomes in 235 patients[J]. Ann Surg ,1999, 229: 693-698; discussion 698-700.[22] Bassi C, Falconi M, Molinari E, et al. Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study[J]. Ann Surg, 2005, 242: 767-771, discussion 771-773.[23] Richardson DQ, Scott-Conner CE. Distal pancreatectomy with and without splenectomy. A comparative study[J]. Am Surg, 1989, 55: 21-25.[24] Aldridge MC, Williamson RC. Distal pancreatectomy with and without splenectomy[J]. Br J Surg, 1991, 78: 976-979.[25] Lee SY, Goh BK, Tan YM, et al. Spleen-preserving distal pancreatectomy[J]. Singapore Med J, 2008, 49: 883-885.[26] Warshaw AL. Conservation of the spleen with distal pancreatectomy[J]. Arch Surg, 1988, 123: 550-553.[27] Warshaw AL, Rattner DW, Z'graggen K. Middle segment pancreatectomy: a novel technique for conserving pancreatic tissue[J]. Arch Surg, 1998, 133: 327-331.[28] 王成锋,张建伟,刘骞,等. 胰腺中央切除术在胰腺外科中的应用. 第七届全国胰腺癌研究进展暨规范化诊治学术研讨会论文集,威海,2010. 北京:人民卫生出版社,2010:319-321.[29] Roggin KK, Rudloff U, Blumgart LH, et al. Central pancreatectomy revisited[J]. J Gastrointest Surg, 2006; 10: 804-812.[30] Iacono C, Bortolasi L, Serio G. Is there a place for central pancreatectomy in pancreatic surgery? [J]. J Gastrointest Surg,1998, 2: 509-516.[31] Crippa S, Salvia R, Warshaw AL, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients[J]. Ann Surg, 2008, 247: 571-579.[32] Crippa S, Bassi C, Salvia R, et al. Enucleation of pancreatic neoplasms[J]. Br J Surg, 2007, 94: 1254-1259.[33] Bassi C, Falconi M, Salvia R, et al. Management of complications after pancreaticoduo-denectomy in a high volume centre: results on 150 consecutive patients[J]. Dig Surg, 2001, 18: 453-457.[34] Reddy RP, Smyrk TC, Zapiach M, et al . Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer[J]. Clin Gastroenterol Hepatol, 2004, 2: 1026-1031.[35] Pan ZG, Wang B. Anaplastic carcinoma of the pancreas associated with a mucinous cystic adenocarcinoma[J]. A case report and review of the literature. JOP, 2007, 8: 775-782.[36] Beger HG, Rau BM, Gansauge F, et al. Duodenum-preserving total pancreatic head resection for cystic neoplasm: a limited but cancer-preventive procedure[J]. Langenbecks. Arch Surg. 2008, 393: 589-598.[37] Beger HG, Büchler M, Bittner RR, et al. Duodenum-preserving resection of the head of the pancreas in severe chronic pancreatitis[J]. Ann Surg, 1989, 209: 273-278.[38] Melotti G, Butturini G, Piccoli M, et al. Laparoscopic distal pancreatectomy: results on a consecutive series of 58 patients[J]. Ann Surg, 2007, 246: 77-82.[39] Laxa BU, Carbonell AM 2nd, Cobb WS, et al. Laparoscopic and hand-assisted distal pancreatectomy[J]. Am Surg, 2008, 74: 481-486.[40] Fernández-Cruz L, Cosa R, Blanco L, et al. Curative laparoscopic resection for pancreatic neoplasms: a critical analysis from a single institution[J]. J Gastrointest Surg, 2007, 11: 1607-1621.[41] Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial[J]. J Clin Oncol, 1997; 15:2403-2413.[42] Shimada K, Iwase K, Aono T, et al. A case of advanced mucinous cystadenocarcinoma of the pancreas with peritoneal dissemination responding to gemcitabine[J]. Gan To Kagaku Ryoho, 2009, 36: 995-998.[43] Rivera F, López-Tarruella S, Vega-Villegas ME, et al. Treatment of advanced pancreatic cancer: from gemcitabine single agent to combinations and targeted therapy[J]. Cancer Treat Rev, 2009, 35: 335-339.[44] Allen PJ, D'Angelica M, Gonen M, et al. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients[J]. Ann Surg ,2006, 244: 572-582.[45] Garcea G, Dennison AR, Pattenden CJ, et al. Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature[J]. JOP, 2008, 9: 99-132.[46] Allen PJ, D'Angelica M, Gonen M, et al. A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients[J]. Ann Surg ,2006, 244: 572-582. |
| [1] | LIU Li-qiang, LI Wen-bin, YE Hui-lin. Prediction of prognosis of pancreatic cancer patients after operation by enhanced CT extracellular volume fraction [J]. Lingnan Modern Clinics In Surgery, 2024, 24(03): 141-149. |
| [2] | XU Yao-peng, ZHANG Cong, LIU Bi-ren, LI Song, LU Yi-jie, JIANG Xin-wei, WU Jian-wu. Study on the application of three-dimensional visualization technique in laparoscopic pancreaticoduodenectomy [J]. Lingnan Modern Clinics In Surgery, 2023, 23(05): 431-435. |
| [3] | LONG Yin, SONG Xing-dong, ZHANG Lei. Several focus issues of conversion therapies for intermediate-advanced hepatocellular carcinoma [J]. Lingnan Modern Clinics In Surgery, 2022, 22(02): 115-119. |
| [4] | DENG Jing, CHEN Huan-wei. Comparative study on the safety and efficacy of laparoscopic pancreaticoduodenectomy and open pancreaticoduodenectomy [J]. Lingnan Modern Clinics In Surgery, 2022, 22(02): 120-125. |
| [5] | HE Chong, ZHOU Shu-rui, LI Ya-qing, CHEN Shao-jie, LIAN Guo-da, CHEN Shang-xiang, HUANG Kai-hong. Screening of ferroptosis-related genes and construction of prognostic prediction model in pancreatic cancer [J]. Lingnan Modern Clinics In Surgery, 2022, 22(01): 14-23. |
| [6] | LIN Xing-yi, TIAN Zhen-feng, PAN Le-le, SU Ming-xin, CHEN Yin-ting. Metabolic pathways and key gene analysis of circulating tumor cells in pancreatic cancer based on GEO database [J]. Lingnan Modern Clinics In Surgery, 2022, 22(01): 34-41. |
| [7] | CHENG Hao, QIU Yu⁃dong. Application of circulating tumor cells in diagnosis and treatment of pancreatic cancer [J]. Lingnan Modern Clinics In Surgery, 2021, 21(02): 141-145. |
| [8] | LOU Wen-hui. Whole disease journey management in the diagnosis and treatment of pancreatic cancer [J]. Lingnan Modern Clinics In Surgery, 2021, 21(01): 1-5. |
| [9] | HAN Shi-ji, LIAN Guo-da, CHEN Shao-jie, HUANG Kai-hong, LI Jia-jia. Construction and functional verification of immortalized human pancreatic stellate cells [J]. Lingnan Modern Clinics In Surgery, 2021, 21(01): 36-43. |
| [10] | YUAN Guan-ping, JIANG Zhi-min, MA Dong, PAN Zi-chun, DING Ying, XIE De-rong. FOLFIRINOX regimen versus AG regimen as first-line therapy in advanced pancreatic cancer: A multicenter observational study [J]. Lingnan Modern Clinics In Surgery, 2021, 21(01): 53-58. |
| [11] | HUANG Xian-xian, LI Yuan-hua, HUANG Feng-ting, ZHANG Shi-neng, ZHUANG Yan-yan.. Effect on biological function after XPO1 knockout in pancreatic cancer cell line via CRISPR/Cas9 [J]. Lingnan Modern Clinics in Surgery, 2020, 20(03): 280-284. |
| [12] | PENG Ning-fu, ZHONG Jian-hong, ZHU Shao-liang, LIAO Ying-yang, LI Le-qun. Research status of commonality between cancerous and precancerous lesions of the biliary tract and the pancreas [J]. Lingnan Modern Clinics in Surgery, 2020, 20(02): 261-266. |
| [13] | LI Xuan-na, CHEN Shang-xiang, LIAN Guo-da, CHEN Shao-jie, HUANG Kai-hong. Analysis of clinicopathological features of 240 cases of pancreatic cancer with liver metastasis and prognostic risk factors [J]. Lingnan Modern Clinics in Surgery, 2020, 20(02): 151-154. |
| [14] | LI Zitao, MIAO Huilai. Advances in the diagnosis and treatment of pancreatic cystic tumors by endoscopic ultrasonography [J]. Lingnan Modern Clinics in Surgery, 2019, 19(01): 106-109. |
| [15] | REN Xiaofan1, LI zhihua1. Expression and clinical significance of exosomal long non?coding RNA CCAT1 in pancreatic cancer [J]. Lingnan Modern Clinics in Surgery, 2019, 19(01): 23-27. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||